Phage Display-Derived Oligopeptides-Functionalized Probes for in vivo Specific Photoacoustic Imaging of Osteosarcoma

Abstract Specific detection of various tumor types remains crucial for designing effective treatment strategies. We demonstrate photoacoustic imaging (PAI) using high-affinity and high-specificity peptide-based probes for accurate and specific diagnosis of osteosarcoma. Herein, two new tumor-specifi...

Full description

Saved in:
Bibliographic Details
Published inNanomedicine
Main Authors Ma, Zebin, Qin, Huan, Chen, Hongjiang, Yang, Hailong, Xu, Jiankun, Yang, Sihua, Hu, Jun, Xing, Da
Format Journal Article
LanguageEnglish
Published 2016
Subjects
Internal Medicine
phage display
oligopeptides
photoacoustic imaging
osteosarcoma
Online AccessGet full text

Cover

More Information
Summary:Abstract Specific detection of various tumor types remains crucial for designing effective treatment strategies. We demonstrate photoacoustic imaging (PAI) using high-affinity and high-specificity peptide-based probes for accurate and specific diagnosis of osteosarcoma. Herein, two new tumor-specific oligopeptides, termed PT6 and PT7, were identified using phage display-based screening on an osteosarcoma cell line (UMR-106). The identified oligopeptides were able to detect clinical osteosarcoma samples on tissue microarrays. Oligopeptides-conjugated PEGylated gold nanorods (PGNR) were designed to specifically target UMR-106 cells. More importantly, PAI revealed that both PGNR-PT6 and PGNR-PT7 could bind selectively to subcutaneous UMR-106 xenografts after systemic administration, and enhance the contrast of osteosarcoma images by 170% and 230%, respectively, compared to tumor-bearing mice injected with PGNRs conjugated to scrambled oligopeptides. PAI employing PGNRs conjugated to specifically designed nanoprobes may provide a new method for tumor type-specific diagnosis of osteosarcoma.
ISSN:1549-9634
DOI:10.1016/j.nano.2016.09.002